Knowledge Summary image

Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dogs Diagnosed With a Degenerative Joint Process?

Adam Swallow

Published:  26/01/2016    in:  Knowledge Summaries
Views
1322
HTML:
993
PDF:
493



Knowledge Summary image
Abstract

Clinical bottom line

At normal clinical doses, there is no evidence that robenacoxib would provide superior patient comfort compared to meloxicam.

Full Text:

HTML PDF


Click to see References Click to hide References
References

  1. Schmid, V.B. et al. (2009) Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. Journal of Veterinary Pharmacology and Therapeutics, 33 (2), pp. 118-131. http://dx.doi.org/10.1111/j.1365-2885.2009.01117.x


Refbacks
  • There are currently no refbacks.


Copyright (c) 2016 Adam Swallow

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Made possible through a project grant from the RCVS Council.

RCVS